Table of Contents

Historical overview of the development of genotoxic impurities guidelines and their impact / R. Ogilvie, A. Teasdale.
Development of the threshold of toxicological concern concept (TTC) and its relationship to duration of exposure / A. Brigo, L. Müller.
Genetic toxicity testing to qualify alerting impurities / M. O'Donovan.
Use of structure activity relationship (SAR) evaluation as a critical tool in the evaluation of the genotoxic potential of impurities / S. Glowienke, C. Hasselgren.
Compound-specific risk assessments for genotoxic impurities : examples and issues / A. Teasdale, C. Humfrey.
Human genotoxic metabolites : identification and risk / K. Dobo, D. Walker, A. Teasdale.
Genotoxic thresholds / G. Jenkins ... [et al.].
Genotoxic impurities : a risk in perspective? / D. Elder, J. Harvey.
Strategies for the evaluation of genotoxic impurity risk / A Teasdale, S. Fenner, D. Elder.
Analysis of genotoxic impurities : review of approaches / D. Elder.
Development of a strategy for analysis of genotoxic impurities / Andrew Baker.
Strategic approaches to the chromatographic analysis of genotoxic impurities / Frank David ... [et al.].
Analysis of genotoxic impurities by nuclear magnetic resonance (NMR) spectroscopy / Andrew Philips.
Mechanism and processing parameters affecting the formation of sulfonate esters : summary of the PQRI studies : PQRI working group / Andrew Teasdale.
Aspects to consider when devising a strategy to understand if low level API/DP degradants have the potential for genotoxicity / Alan P. McKeown, Andrew Teasdale. This book examines genotoxic impurities and their impact on the pharmaceutical industry. Specific sections examine this from both a toxicological and analytical perspective. Within these sections, the book defines appropriate strategies to both assess and ultimately control genotoxic impurities, thus aiding the reader to develop effective control measures. An opening section covers the development of guidelines and the threshold of toxicological concern (TTC) and is followed by a section on safety aspects, including safety tests in vivo and vitro, and data interpretation. T.
This book examines genotoxic impurities and their impact on the pharmaceutical industry. Specific sections examine this from both a toxicological and analytical perspective. Within these sections, the book defines appropriate strategies to both assess and ultimately control genotoxic impurities, thus aiding the reader to develop effective control measures. An opening section covers the development of guidelines and the threshold of toxicological concern (TTC) and is followed by a section on safety aspects, including safety tests in vivo and vitro, and data interpretation. T.
Teasdale, Andrew
-
Wiley
2011
9780470929360
9780470499191
RefWorks